Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Interleukin-2 in Women With Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
Latest Information Update: 05 Nov 2021
Price :
$35 *
At a glance
- Drugs FATE NK100 (Primary) ; Cyclophosphamide; Fludarabine; Interleukin-2
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions
- Acronyms APOLLO
- 10 Mar 2021 Status changed from active, no longer recruiting to completed.
- 12 Aug 2020 Planned number of patients changed from 16 to 10.
- 12 Aug 2020 Status changed from recruiting to active, no longer recruiting.